Dechert LLP has a dedicated Hatch-Waxman team with extensive experience in litigating Abbreviated New Drug Applications (ANDAs). Having taken on and won cases involving as many as a dozen ANDA filers, we regularly take these disputes to trial. When necessary, our team is adept at handling follow-on antitrust litigation.